secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensei Biotherapeutics, Inc. (SNSE)
CIK:        0001829802
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0001193125-24-059356
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensei Biotherapeutics extends stockholder rights plan to March 2025, removes 'acting in concert' definition
--------------------------------------------------------------------------------

- Second Amendment to Rights Agreement extends expiration date to March 7, 2025 (from March 7, 2024).
- The amendment eliminates the 'acting in concert' beneficial ownership provision from the Rights Agreement.
- Rights remain subject to earlier redemption, exchange, or termination per the agreement.
- Amendment is between Sensei Biotherapeutics and Equiniti Trust Company, LLC, as Rights Agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829802/000119312524059356/0001193125-24-059356-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829802/000119312524059356/d792997d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-059356

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer